For the past several years, the Mighty Moose - alongside Kicks for Cancer - has invested in the MiDe Study research program, helping to develop a new ovarian cancer early detection test using microRNA technology. Ovarian cancer continues to have the highest mortality rate of all female reproductive cancers, primarily due to late-stage diagnosis.
This year, our investment reaches a turning point marking our shift from making a test to implementing a testing program.
Your 2026 donations will help fund the ORBIT Study led by Dr. Kevin Elias in partnership with Cleveland Clinic and Dana-Farber Cancer Institute. ORBIT is the first clinical study related to doctors and patients utilizing the OVAinform test (which incorporates the microRNA ovarian cancer early detection technology).
This is a bridge between years of research and a future where ovarian cancer is caught earlier, treated sooner, and eventually screened for as part of routine women's healthcare.
If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.
If you continue to use this site, you consent to use all cookies.
We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.
